Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Anti-HIV-1 activity of aciclovir and potentiation by ribavirin

Jan. 3, 2011

CADA blocks HIV entry by disrupting translocation of CD4 across ER membrane

Dec. 31, 2010

Efficacy and safety data from ECHO and THRIVE trials of rilpivirine reported

Dec. 31, 2010

DermaPrep-delivered LC-002 shows promise in phase I/II trials in HIV

Dec. 31, 2010

Scientists unveil mechanism leading to resistance of HIV to maraviroc

Dec. 30, 2010

PF-3450074 inhibits HIV infection by destabilizing viral capsid

Dec. 30, 2010

Interim analysis of SENSE trial data shows superior safety of etravirine vs. efavirenz in HIV

Dec. 29, 2010

ODE-(S)-HPMPA and ODE-(S)-HPMPC inhibit HIV replication by new mode of action

Dec. 29, 2010

Gel formulation of IQP-0528 plus tenofovir evaluated in vitro as HIV therapy

Dec. 28, 2010

Asymmetrical CADA analogue VGD-020 displays improved potency against CD4

Dec. 28, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...